Merit Medical Systems Inc (MMSI)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Merit Medical Systems Inc (MMSI)
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.
Key Insights
Critical company metrics and information
Share Price
$104.40Market Cap
$6.08 BillionTotal Outstanding Shares
58.28 Million SharesTotal Employees
6,950Dividend
No dividendIPO Date
February 26, 1992SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.merit.com
Historical Stock Splits
If you bought 1 share of MMSI before August 15, 2003, you'd have 2.22 shares today.
Execution Date | Split Amount |
---|---|
May 6, 2011 | 5-for-4 |
December 3, 2003 | 4-for-3 |
August 15, 2003 | 4-for-3 |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities, Continuing | $-162.55 Million |
Net Cash Flow From Financing Activities, Continuing | $410.37 Million |
Net Cash Flow, Continuing | $462.13 Million |
Net Cash Flow From Operating Activities, Continuing | $214.31 Million |
Net Cash Flow | $462.13 Million |
Net Cash Flow From Financing Activities | $410.37 Million |
Net Cash Flow From Operating Activities | $214.31 Million |
Net Cash Flow From Investing Activities | $-162.55 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Income/Loss Available To Common Stockholders, Basic | $120.04 Million |
Gross Profit | $620.88 Million |
Net Income/Loss Attributable To Parent | $120.04 Million |
Cost Of Revenue | $704.99 Million |
Costs And Expenses | $1.18 Billion |
Provision For Loan, Lease, And Other Losses | $1.27 Million |
Diluted Earnings Per Share | $2.05 |
Operating Income/Loss | $152.74 Million |
Operating Expenses | $468.14 Million |
Diluted Average Shares | $118.20 Million |
Selling, General, and Administrative Expenses | $384.41 Million |
Other Operating Expenses | $83.73 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Benefits Costs and Expenses | $1.18 Billion |
Net Income/Loss | $120.04 Million |
Basic Earnings Per Share | $2.07 |
Basic Average Shares | $116.35 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Income/Loss From Continuing Operations Before Tax | $148.31 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Nonoperating Income/Loss | $-4.43 Million |
Income/Loss From Continuing Operations After Tax | $120.04 Million |
Revenues | $1.33 Billion |
Income Tax Expense/Benefit | $28.28 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Fixed Assets | $389.65 Million |
Liabilities | $1.05 Billion |
Current Assets | $1.08 Billion |
Equity Attributable To Parent | $1.32 Billion |
Other Non-current Liabilities | $103.09 Million |
Noncurrent Assets | $1.30 Billion |
Inventory | $310.53 Million |
Equity | $1.32 Billion |
Other Current Assets | $767.79 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Liabilities And Equity | $2.38 Billion |
Current Liabilities | $201.08 Million |
Other Non-current Assets | $910.11 Million |
Noncurrent Liabilities | $853.60 Million |
Long-term Debt | $750.50 Million |
Assets | $2.38 Billion |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Related Companies
View additional S&P 500 companies similar to Merit Medical Systems Inc (MMSI)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.